Dyanavel Xr
Payments companies reported to CMS as associated with Dyanavel Xr. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dyanavel Xr, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dyanavel Xr
These are the largest totals companies reported as associated with Dyanavel Xr. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joel Young | Rochester Hills, MI | Psychiatry | $576,682.07 |
| Michael Feld | Northbrook, IL | Psychiatry | $200,129.88 |
| Alice Mao | Houston, TX | Psychiatry | $48,446.66 |
| Mark Wright | Lexington, KY | Psychiatry | $36,185.79 |
| Cathal Grant | Bedford, TX | Psychiatry | $35,730.48 |
| Victor Abdow | Rockville, MD | Pediatrics | $33,717.47 |
| Dustin Jasmer | Layton, UT | Family | $32,349.04 |
| Andrew Cutler | Watertown, MA | Internal Medicine | $29,283.82 |
| Herman Clements | Searcy, AR | Psychiatry | $27,178.18 |
| Louis Cady | Newburgh, IN | Psychiatry | $25,210.43 |
Prescribed Dyanavel Xr?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.